
Overview
Sandeep Dave is a Hematologist Oncology specialist and an Oncologist in Durham, North Carolina. Dr. Dave is rated as an Advanced provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, and Bone Marrow Aspiration. Dr. Dave is currently accepting new patients.
His clinical research consists of co-authoring 83 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of T-Cell Lymphoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Anne Beaven is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Beaven is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
Duke Blood Cancer Center
I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. De Castro Iii is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.
Duke Blood Cancer Center
I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists. Dr. Stefanovic is rated as a Distinguished provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Waldenstrom Macroglobulinemia, Diffuse Large B-Cell Lymphoma (DLBCL), Marginal Zone Lymphoma (MZL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaDr. Dave isDistinguished. Learn about B-Cell Lymphoma.
- Burkitt LymphomaDr. Dave isDistinguished. Learn about Burkitt Lymphoma.
- Non-Hodgkin LymphomaDr. Dave isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- T-Cell LymphomaDr. Dave isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Dave isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Dr. Dave isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Dave isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Angioimmunoblastic T-cell LymphomaDr. Dave isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Bone Marrow AspirationDr. Dave isExperienced. Learn about Bone Marrow Aspiration.
- Chronic B-Cell Leukemia (CBCL)Dr. Dave isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).

